PharmaShots | Incisive News in 3 Shots

Subscribe Now

ALL

Cellectis Collaborates with Sanofi for Alemtuzumab to be Utilized in CART-Cell Trials

Cellectis Collaborates with Sanofi for Alemtuzumab to be Utilized in CART-Cell Trials

May 12, 2021

Foundation Medicine's FoundationOne CDx Receives the US FDA's Approval as a CDx for Vitrakvi (larotrectinib)

Foundation Medicine's FoundationOne CDx Receives the US FDA's Approval as a CDx for Vitrakvi (larotrectinib)

October 26, 2020

Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indications

Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indicat...

August 13, 2020

Samsung Bioepis Eticovo's (etanercept-ykro- biosmilar) Receives FDA's Approval for All Eligible Indication

Samsung Bioepis Eticovo's (etanercept-ykro- biosmilar) Receives FDA's Approval for All Eligible Indication

April 29, 2019

Amgen's Blincyto (blinatumomab) Receives EU Expanded Indication Approval for Ph- CD19 Positive B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Amgen's Blincyto (blinatumomab) Receives EU Expanded Indication Approval for Ph- CD19 Positive B-cell Precursor Acute Lymphoblasti...

January 23, 2019

Bristol-Myers' Sprycel (dasatinib) Receives CHMP Recommendation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL)

Bristol-Myers' Sprycel (dasatinib) Receives CHMP Recommendation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia...

December 18, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us